RXRX
Price
$4.61
Change
+$0.09 (+1.99%)
Updated
Sep 5 closing price
Capitalization
2.01B
60 days until earnings call
TLPPF
Price
$9.04
Change
-$0.18 (-1.95%)
Updated
Sep 5 closing price
Capitalization
3.02B
Interact to see
Advertisement

RXRX vs TLPPF

Header iconRXRX vs TLPPF Comparison
Open Charts RXRX vs TLPPFBanner chart's image
Recursion Pharmaceuticals
Price$4.61
Change+$0.09 (+1.99%)
Volume$13.76M
Capitalization2.01B
Telix Pharmaceutical
Price$9.04
Change-$0.18 (-1.95%)
Volume$569
Capitalization3.02B
RXRX vs TLPPF Comparison Chart in %
Loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RXRX vs. TLPPF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXRX is a Buy and TLPPF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (RXRX: $4.61 vs. TLPPF: $9.04)
Brand notoriety: RXRX and TLPPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RXRX: 59% vs. TLPPF: 7%
Market capitalization -- RXRX: $2.01B vs. TLPPF: $3.02B
RXRX [@Biotechnology] is valued at $2.01B. TLPPF’s [@Biotechnology] market capitalization is $3.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXRX’s FA Score shows that 1 FA rating(s) are green whileTLPPF’s FA Score has 1 green FA rating(s).

  • RXRX’s FA Score: 1 green, 4 red.
  • TLPPF’s FA Score: 1 green, 4 red.
According to our system of comparison, TLPPF is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXRX’s TA Score shows that 4 TA indicator(s) are bullish while TLPPF’s TA Score has 4 bullish TA indicator(s).

  • RXRX’s TA Score: 4 bullish, 5 bearish.
  • TLPPF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TLPPF is a better buy in the short-term than RXRX.

Price Growth

RXRX (@Biotechnology) experienced а -1.91% price change this week, while TLPPF (@Biotechnology) price change was -8.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLPPF($3.02B) has a higher market cap than RXRX($2.01B). RXRX YTD gains are higher at: -31.805 vs. TLPPF (-39.633). TLPPF has higher annual earnings (EBITDA): 92.5M vs. RXRX (-583.64M). TLPPF has more cash in the bank: 710M vs. RXRX (525M). RXRX has less debt than TLPPF: RXRX (88.1M) vs TLPPF (581M). TLPPF has higher revenues than RXRX: TLPPF (783M) vs RXRX (64.5M).
RXRXTLPPFRXRX / TLPPF
Capitalization2.01B3.02B67%
EBITDA-583.64M92.5M-631%
Gain YTD-31.805-39.63380%
P/E RatioN/A387.72-
Revenue64.5M783M8%
Total Cash525M710M74%
Total Debt88.1M581M15%
FUNDAMENTALS RATINGS
TLPPF: Fundamental Ratings
TLPPF
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
56
SMR RATING
1..100
68
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RXRXTLPPF
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 5 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJIZX9.54N/A
N/A
PGIM Quant Solutions International Eq Z
FDIVX49.84N/A
N/A
Fidelity Diversified International
AABCX16.40N/A
N/A
Putnam Dynamic Asset Allocation Bal C
NGCAX41.75N/A
N/A
Columbia Greater China A
EPSIX24.87N/A
N/A
NYLI Epoch Global Equity Yield Inv Class

TLPPF and

Correlation & Price change

A.I.dvisor tells us that TLPPF and GLMD have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPPF and GLMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPPF
1D Price
Change %
TLPPF100%
-1.95%
GLMD - TLPPF
25%
Poorly correlated
+6.25%
DNLI - TLPPF
24%
Poorly correlated
+4.33%
BEAM - TLPPF
24%
Poorly correlated
+12.62%
RXRX - TLPPF
23%
Poorly correlated
+1.99%
JANX - TLPPF
23%
Poorly correlated
+0.17%
More